Fort Sheridan Advisors LLC Biogen Inc. Transaction History

Fort Sheridan Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $19,052 - $23,672	-100 Reduced 9.35%	970 $224,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $15,901 - $20,078	75 Added 7.54%	1,070 $230,000
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $252,033 - $284,460	995 New	995 $255,000
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $174,831 - $241,077	898 New	898 $240,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $246,312 - $316,547	-1,100 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $28,299 - $36,905	-100 Reduced 8.33%	1,100 $311,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $70,878 - $106,689	300 Added 33.33%	1,200 $294,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $232,794 - $308,295	900 New	900 $241,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Sheridan Advisors LLC with notifications on news.